Seroepidemiology of Japanese Encephalitis Virus Infection in Hualien, Taiwan
NCT ID: NCT01163123
Last Updated: 2010-07-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
312 participants
OBSERVATIONAL
2010-05-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Children's Susceptibility to Enterovirus 71 in Different Areas of Taiwan
NCT01311921
Hepatitis B Seroepidemiology Among Young Adults
NCT01973582
Seroprevalence of Hepatitis B Infection and Effect of Booster Response Amongst Taiwanese Young Adults
NCT00702663
The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort
NCT04970836
Clinical Course Study in Chronic Hepatitis B After Nucleos(t)Ide Analogue Therapy
NCT02582333
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In order to understand the risk of JEV infection and environmental (mosquito, swine) surveillance, we had arranged a small cohort study in 2 villages. The 2 villages are located at middle Hualien with direct distance around 20 KM between each other. Both villages had several pig farms and mosquito numbers in summer were very high. Both villages had document JEV infection resident in past 2 years. The first village was near the river ready to entrance the sea (wetlands) and many migrate birds appeared in the summer every year. The residence were mostly Han people. The seconds village was located very closed to the central mountain Taiwan and the residence were almost aboriginal people.
In this year 2010, we plan to do the following research:
1. Collect mosquito in 2 villages since May.2010 with RT-PCT method to identify the JEV genotype
2. Collect sera from swine in 2 villages to identify the JEV genotype
3. Collect sera from 312 residency in 2 villages at May and Sep 2010 to detect sub-clinical infection rate. ( estimated sub-clinical infection rate = 2.5%)
4. Identify the JEV from new diagnosed patient in 2010.
Since virus was hardly detected by RT-PCR or virus isolation from JEV infected patient, the virus identified from mosquito or swine in the nearby may show indirect evidence of the JEV genotype.
After comparing the 2 sera from the same person during the summer in these 2 villages, we can identify:
1. The subclinical infection rate of the JEV (genotype I or III, depends on JEV isolated from mosquito)
2. Whether aboriginal people near the central mountains are at more risk then people near the wetlands.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Aged 18-85
Exclusion Criteria
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mennonite Christian Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mennonite Christian Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ChenChang Shih
Role: STUDY_DIRECTOR
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D9902
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.